|
|
.
See Category: Neoplasms
See Header: Secondary carcinoid tumors
ICD-10 (CM) Code and Descriptor
|
C7B.01 |
Secondary carcinoid tumors of distant lymph nodes
|
C7B01 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 5.58%
|
34.54%
|
27.11%
|
13.17%
|
6.59%
|
3.38%
|
2.85%
|
3.17%
|
1.63%
|
0.51%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C7B.01*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
95
|
104
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
86
|
87
|
|
80053
|
COMPREHEN METABOLIC PANEL |
84
|
84
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
73
|
73
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
72
|
73
|
|
J2353
|
OCTREOTIDE INJECTION, DEPOT |
51
|
1,710
|
|
J1930
|
LANREOTIDE INJECTION |
34
|
4,080
|
|
88341
|
IMHCHEM/IMCYTCHM EA ADD ANTB |
28
|
91
|
|
A9513
|
LUTETIUM LU 177 DOTATAT THER |
23
|
2,400
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
21
|
292
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
20
|
34
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
19
|
2,190
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
18
|
19
|
|
J0185
|
INJ., APREPITANT, 1 MG |
14
|
1,820
|
|
88173
|
CYTOPATH EVAL FNA REPORT |
12
|
22
|
|
79101
|
NUCLEAR RX IV ADMIN |
12
|
12
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
11
|
369
|
|
86316
|
IMMUNOASSAY TUMOR OTHER |
11
|
11
|
|
71260
|
CT THORAX DX C+ |
10
|
10
|
|
88360
|
TUMOR IMMUNOHISTOCHEM/MANUAL |
10
|
10
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C7B.01 related to the following DRG Codes:
820-822
823-825
840-842
|
